A prospective randomized study of alpha-2b interferon plus hydroxyurea or cytarabine for patients with early chronic phase chronic myelogenous leukemia: the …
FJ Giles, J Shan, S Chen, SH Advani… - Leukemia & …, 2000 - Taylor & Francis
A prospective randomized international study of 143 patients showed no apparent early
survival advantage conferred by combining cytarabine, rather than hydroxyurea, with INF as …
survival advantage conferred by combining cytarabine, rather than hydroxyurea, with INF as …
A prospective randomized study of alpha-2b interferon plus hydroxyurea or cytarabine for patients with early chronic phase chronic myelogenous leukemia: The …
FJ Giles, J Shan, S Chen, SH Advani… - Leukemia and …, 2000 - hub.tmu.edu.tw
摘要A prospective randomized international study of 143 patients showed no apparent early
survival advantage conferred by combining cytarabine, rather than hydroxyurea, with INF as …
survival advantage conferred by combining cytarabine, rather than hydroxyurea, with INF as …
A prospective randomized study of alpha-2b interferon plus hydroxyurea or cytarabine for patients with early chronic phase chronic myelogenous leukemia: The …
FJ Giles, J Shan, S Chen, SH Advani… - Leukemia and …, 2000 - scholars.northwestern.edu
A prospective randomized international study of 143 patients showed no apparent early
survival advantage conferred by combining cytarabine, rather than hydroxyurea, with INF as …
survival advantage conferred by combining cytarabine, rather than hydroxyurea, with INF as …
A prospective randomized study of alpha-2b interferon plus hydroxyurea or cytarabine for patients with early chronic phase chronic myelogenous leukemia: the …
FJ Giles, J Shan, S Chen, SH Advani… - Leukemia & …, 2000 - pubmed.ncbi.nlm.nih.gov
A prospective randomized international study of 143 patients showed no apparent early
survival advantage conferred by combining cytarabine, rather than hydroxyurea, with INF as …
survival advantage conferred by combining cytarabine, rather than hydroxyurea, with INF as …
A prospective randomized study of alpha-2b interferon plus hydroxyurea or cytarabine for patients with early chronic phase chronic myelogenous leukemia: the …
FJ Giles, J Shan, S Chen, SH Advani… - Leukemia & …, 2000 - europepmc.org
A prospective randomized international study of 143 patients showed no apparent early
survival advantage conferred by combining cytarabine, rather than hydroxyurea, with INF as …
survival advantage conferred by combining cytarabine, rather than hydroxyurea, with INF as …
A prospective randomized study of alpha-2b interferon plus hydroxyurea or cytarabine for patients with early chronic phase chronic myelogenous leukemia: The …
FJ Giles, J Shan, S Chen, SH Advani… - Leukemia and …, 2000 - hub.tmu.edu.tw
A prospective randomized international study of 143 patients showed no apparent early
survival advantage conferred by combining cytarabine, rather than hydroxyurea, with INF as …
survival advantage conferred by combining cytarabine, rather than hydroxyurea, with INF as …